Featured Research

from universities, journals, and other organizations

Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease

Date:
November 28, 2006
Source:
American Chemical Society
Summary:
Efforts to understand the link between the cyclooxygenase-2 (COX-2) inhibitor arthritis drugs and heart disease have had an unanticipated benefit in leading to development of an engineered protein with "great potential" as a new treatment for heart disease, according to a new scientific report.

Efforts to understand the link between the cyclooxygenase-2 (COX-2) inhibitor arthritis drugs and heart disease have had an unanticipated benefit in leading to development of an engineered protein with "great potential" as a new treatment for heart disease, according to a new scientific report.

In an article scheduled for the Nov. 28 issue of the ACS weekly journal Biochemistry, University of Texas's Ke-He Ruan and colleagues point out that the COX-2 drugs like the banned Vioxx have beneficial anti-inflammatory effects for arthritis.

However, studies now suggest that those drugs also may increase the risk of heart attacks and strokes by decreasing the body's production of prostacyclin (a blood vessel protector that dilates blood vessels and prevents blood clots) and increasing production of thromboxane (which constricts vessels and promotes clot formation).

A drug that increases prostacyclin levels and decreases thromboxane could be an ideal way to prevent and treat inflammation and cardiovascular disease, they state. Ruan's group reports taking a step in that direction.

They report linking together two enzymes to engineer a protein to form a "Super Enzyme" with three catalytic functions that makes cells grown in laboratory cultures continuously produce protective prostacyclin. The enzyme has advantages over another proposed strategy that involves increasing prostacyclin levels by administering the COX gene into cells, they add.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease." ScienceDaily. ScienceDaily, 28 November 2006. <www.sciencedaily.com/releases/2006/11/061128084827.htm>.
American Chemical Society. (2006, November 28). Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2006/11/061128084827.htm
American Chemical Society. "Engineering The 'Super Enzyme' -- A Potential New Weapon Against Heart Disease." ScienceDaily. www.sciencedaily.com/releases/2006/11/061128084827.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins